Publicaciones en las que colabora con Ana Villegas (16)

2020

  1. Autoimmune haemolytic anaemias: A retrospective study of 93 patients

    Medicina Clinica, Vol. 154, Núm. 9, pp. 331-337

2017

  1. Phenotype of mutations in the promoter region of the β-globin gene

    Journal of Clinical Pathology, Vol. 70, Núm. 10, pp. 874-878

  2. Presence of acute and chronic renal failure in patients with paroxysmal nocturnal hemoglobinuria: results of a retrospective analysis from the Spanish PNH Registry

    Annals of Hematology, Vol. 96, Núm. 10, pp. 1727-1733

2016

  1. Hereditary xerocytosis, a misleading anemia

    Annals of Hematology

  2. Spanish consensus statement for diagnosis and treatment of paroxysmal nocturnal haemoglobinuria

    Medicina Clinica

2015

  1. Evolution of iron overload in patients with low-risk myelodysplastic syndrome: iron chelation therapy and organ complications

    Annals of Hematology, Vol. 94, Núm. 5, pp. 779-787

2011

  1. Darbepoetin alfa for anemia in patients with low or intermediate-1 risk myelodysplastic syndromes and positive predictive factors of response

    Current Medical Research and Opinion, Vol. 27, Núm. 5, pp. 951-960

  2. Diagnóstico y tratamiento de la hemoglobinuria paroxística nocturna

    Medicina Clinica

2010

  1. Deferasirox in iron-overloaded patients with transfusion-dependent myelodysplastic syndromes: Results from the large 1-year EPIC study

    Leukemia Research, Vol. 34, Núm. 9, pp. 1143-1150

  2. Iron overload and chelation therapy in patients with low-risk myelodysplastic syndromes with transfusion requirements

    Annals of Hematology, Vol. 89, Núm. 2, pp. 147-154

2007

  1. Hemoglobina Fannin-Lubbock II [β111(G13)Val → Leu y β119(GH2)Gly → Asp]: Descripción de 4 nuevos casos

    Medicina Clinica, Vol. 129, Núm. 10, pp. 379-381

2005

  1. Estudio del tratamiento con desferroxamina en perfusión subcutánea para la sobrecarga de hierro en pacientes con síndrome mielodisplásico

    Medicina Clinica, Vol. 124, Núm. 17, pp. 645-647

2000

  1. Hb Johnstown [β109 (G11) Val→Leu]: Second case described and associated for the first time with β0-thalassemia in two Spanish families

    American Journal of Hematology, Vol. 65, Núm. 4, pp. 298-301

1999

  1. Erythropoietin plus granulocyte colony-stimulating factor in the treatment of myelodysplastic syndromes. Identification of a subgroup of responders

    Haematologica, Vol. 84, Núm. 12, pp. 1058-1064

1998

  1. Red blood cell phenotypes in α-thalassemias in the Spanish population

    Haematologica, Vol. 83, Núm. 2, pp. 99-103

1997

  1. Identificación de 5 variantes de Hb de cadena ß mediante análisis del ADN (amplificación, secuenciación y enzimas de restricción)

    Sangre, Vol. 42, Núm. 3, pp. 183-187